- Home
- LGO vs CNTB Comparison
LGO vs CNTB Comparison
Compare LGO & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- CNTB
- Stock Information
- Founded
- LGO 1988
- CNTB 2012
- Country
- LGO Canada
- CNTB United States
- Employees
- LGO N/A
- CNTB N/A
- Industry
- LGO
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- CNTB Health Care
- Exchange
- LGO Nasdaq
- CNTB Nasdaq
- Market Cap
- LGO 100.0M
- CNTB 90.3M
- IPO Year
- LGO 2007
- CNTB 2021
- Fundamental
- Price
- LGO $1.75
- CNTB $1.79
- Analyst Decision
- LGO Strong Buy
- CNTB Strong Buy
- Analyst Count
- LGO 1
- CNTB 2
- Target Price
- LGO $3.70
- CNTB $7.50
- AVG Volume (30 Days)
- LGO 434.0K
- CNTB 90.8K
- Earning Date
- LGO 11-11-2025
- CNTB 11-13-2025
- Dividend Yield
- LGO N/A
- CNTB N/A
- EPS Growth
- LGO N/A
- CNTB N/A
- EPS
- LGO N/A
- CNTB N/A
- Revenue
- LGO $108,526,000.00
- CNTB $1,965,000.00
- Revenue This Year
- LGO N/A
- CNTB N/A
- Revenue Next Year
- LGO $54.96
- CNTB $453,067.90
- P/E Ratio
- LGO N/A
- CNTB N/A
- Revenue Growth
- LGO N/A
- CNTB N/A
- 52 Week Low
- LGO $1.12
- CNTB $1.23
- 52 Week High
- LGO $2.84
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- LGO 55.87
- CNTB 55.28
- Support Level
- LGO $1.40
- CNTB $1.36
- Resistance Level
- LGO $1.95
- CNTB $1.58
- Average True Range (ATR)
- LGO 0.16
- CNTB 0.15
- MACD
- LGO -0.02
- CNTB 0.02
- Stochastic Oscillator
- LGO 57.13
- CNTB 81.73
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.